Literature DB >> 8276013

Hyperuricaemia in cyanotic congenital heart disease.

Y Hayabuchi1, S Matsuoka, H Akita, Y Kuroda.   

Abstract

This study examines the exacerbating factors of hyperuricaemia in patients with cyanotic congenital heart disease (CCHD). We studied 59 CCHD patients aged 1 month-30 years. The following variables were assessed: serum uric acid levels, red blood cell count, haemoglobin, hematocrit, partial oxygen pressure and arterial oxygen saturation. Uric acid excretion and renal function were also measured in ten patients with serum levels of uric acid greater than 8 mg/dl (hyperuricaemia group). Serum uric acid level correlated significantly with age and severity of polycythaemia. However, it did not correlate with partial oxygen pressure or arterial oxygen saturation. Uric acid excretion was measured in hyperuricaemia group. Urinary uric acid excretion (24 h) was within normal limits in infants but markedly lower in patients over 15 years of age. The aetiology of hyperuricaemia and decreased uric acid fractional excretion and clearance in infants appears to be secondary to diminished excretion of uric acid in concert with uric acid overproduction. Hyperuricaemia in adolescents and adults with CCHD, however, results mainly from age-related impairment of uric acid excretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8276013     DOI: 10.1007/bf01957519

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Renal function abnormalities in patients with asymptomatic hyperuricemia.

Authors:  J R Klinenberg; H C Gonick; L Dornfeld
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

2.  GOUT IN CYANOTIC CONGENITAL HEART DISEASE.

Authors:  J Somerville
Journal:  Br Heart J       Date:  1961-01

3.  Renal disease in primary gout.

Authors:  K A Barlow; L J Beilin
Journal:  Q J Med       Date:  1968-01

4.  Hyperuricemia in cyanotic congenital heart disease.

Authors:  D Young
Journal:  Am J Dis Child       Date:  1980-09

Review 5.  Adults with cyanotic congenital heart disease: hematologic management.

Authors:  J K Perloff; M H Rosove; J S Child; G B Wright
Journal:  Ann Intern Med       Date:  1988-09-01       Impact factor: 25.391

6.  Abnormal renal functions in cyanotic congential heart disease.

Authors:  J Passwell; S Orda; M Modan; A Shem-Tov; A Aladjem; H Boichis
Journal:  Arch Dis Child       Date:  1976-10       Impact factor: 3.791

7.  Uric acid metabolism in children.

Authors:  L A Baldree; F B Stapleton
Journal:  Pediatr Clin North Am       Date:  1990-04       Impact factor: 3.278

8.  Hyperuricemia in acute illness: a poor prognostic sign.

Authors:  J O Woolliscroft; H Colfer; I H Fox
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

9.  Diagnostic significance of different urinary enzymes in patients suffering from chronic renal diseases.

Authors:  K Jung; B D Schulze; K Sydow
Journal:  Clin Chim Acta       Date:  1987-10-15       Impact factor: 3.786

10.  Impairment of urate excretion in patients with cardiac disease.

Authors:  S E Mace; A J Newman; J Liebman
Journal:  Am J Dis Child       Date:  1984-11
View more
  6 in total

1.  Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.

Authors:  S D Anker; F Leyva; P A Poole-Wilson; W J Kox; J C Stevenson; A J Coats
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

2.  Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome.

Authors:  H Oya; N Nagaya; T Satoh; F Sakamaki; S Kyotani; M Fujita; N Nakanishi; K Miyatake
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

3.  Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?

Authors:  Sergey I Zharikov; Erik R Swenson; Miguel Lanaspa; Edward R Block; Jawaharlal M Patel; Richard J Johnson
Journal:  Med Hypotheses       Date:  2010-01-12       Impact factor: 1.538

4.  Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.

Authors:  Masataka Honda; Hideki Horiuchi; Tomoko Torii; Akihiro Nakajima; Takeshi Iijima; Hiroshi Murano; Hisashi Yamanaka; Shuichi Ito
Journal:  BMC Pediatr       Date:  2021-12-18       Impact factor: 2.125

5.  Long-Term Study on Therapeutic Strategy for Treatment of Eisenmenger Syndrome Patients: A Case Series Study.

Authors:  Yi-Ching Liu; Yu-Wen Chen; I-Chen Chen; Yen-Hsien Wu; Shih-Hsing Lo; Jui-Sheng Hsu; Jong-Hau Hsu; Bin-Nan Wu; Yi-Fang Cheng; Zen-Kong Dai
Journal:  Children (Basel)       Date:  2022-08-12

6.  Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.

Authors:  Shuichi Ito; Tomoko Torii; Akihiro Nakajima; Takeshi Iijima; Hiroshi Murano; Hideki Horiuchi; Hisashi Yamanaka; Masataka Honda
Journal:  BMC Pediatr       Date:  2020-10-15       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.